Betaxolol

Catalog No. A11721

Betaxolol是用于治疗高血压和青光眼的选择性β1受体阻滞剂。由于对β1受体具有选择性,因此与非选择性β受体阻滞剂相比,它通常具有较少的全身性副作用,例如,不会像噻吗洛尔那样引起支气管痉挛(由β2受体介导)。与美托洛尔相比,倍他洛尔对β1受体的亲和力也更高。
Catalog Num A11721
M. Wt 307.43
Formula C18H29NO3
Purity >98%
Storage at -20°C 3 years Powder
CAS No. 63659-18-7
Synonyms Betoptic
SMILES CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O
Betaxolol是用于治疗高血压和青光眼的选择性β1受体阻滞剂。由于对β1受体具有选择性,因此与非选择性β受体阻滞剂相比,它通常具有较少的全身性副作用,例如,不会像噻吗洛尔那样引起支气管痉挛(由β2受体介导)。与美托洛尔相比,倍他洛尔对β1受体的亲和力也更高。
In vitro DMSO 57 mg/mL (185.41 mM)
Water 57 mg/mL (185.41 mM)
Ethanol Insoluble
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
0.1 mM 32.53 mL 162.64 mL 325.28 mL
0.5 mM 6.51 mL 32.53 mL 65.06 mL
1 mM 3.25 mL 16.26 mL 32.53 mL
5 mM 0.65 mL 3.25 mL 6.51 mL

*The above data is based on the productmolecular weight 307.43. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.